Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-18 Sale |
2024-04-22 6:36 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
10,000 | $16.02 | $160,163 | 2,174,662 (Indirect Direct) |
View |
| 2024-03-25 Sale |
2024-03-26 6:09 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
10,000 | $16.01 | $160,055 | 2,184,662 (Indirect Direct) |
View |
| 2024-03-11 Sale |
2024-03-13 4:24 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
30,000 | $15.24 | $457,314 | 2,194,662 (Indirect Direct) |
View |
| 2024-02-27 Sale |
2024-02-28 7:55 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
20,000 | $16.11 | $322,166 | 2,224,662 (Indirect Direct) |
View |
| 2024-02-16 Sale |
2024-02-20 6:48 pm |
Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL |
3,242 | $15.25 | $49,434 | 123,736 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-20 6:36 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY |
2,666 | $15.25 | $40,651 | 411,504 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-20 6:26 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF RESEARCH AND DEVELOPME |
2,258 | $15.25 | $34,430 | 2,359,732 (Indirect Direct) |
View |
| 2024-02-16 Sale |
2024-02-20 6:14 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER |
7,615 | $15.25 | $116,114 | 2,018,042 (Indirect Direct) |
View |
| 2023-11-16 Sale |
2023-11-17 6:33 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
956 | $11.69 | $11,176 | 308,170 (Direct) |
View |
| 2023-11-16 Sale |
2023-11-17 6:30 pm |
Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam General Counsel |
5,313 | $11.69 | $62,109 | 67,978 (Direct) |
View |
| 2023-11-16 Sale |
2023-11-17 6:26 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Head of Research and Developme |
709 | $11.69 | $8,288 | 2,264,990 (Indirect Direct) |
View |
| 2023-11-16 Sale |
2023-11-17 6:20 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
3,107 | $11.69 | $36,321 | 1,838,657 (Indirect Direct) |
View |
| 2023-10-18 Purchase |
2023-10-20 4:02 pm |
Day One Biopharmaceuticals Inc. | DAWN | AI Day1 LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
1,475,454 | $10.15 | $14,978,327 | 12,929,322 (Direct) |
View |
| 2023-08-17 Sale |
2023-08-17 7:02 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
922 | $13.86 | $12,779 | 309,126 (Direct) |
View |
| 2023-08-17 Sale |
2023-08-17 6:21 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Head of Research and Developme |
668 | $13.86 | $9,258 | 2,265,699 (Indirect Direct) |
View |
| 2023-08-17 Sale |
2023-08-17 6:16 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
2,996 | $13.86 | $41,525 | 1,841,764 (Indirect Direct) |
View |
| 2023-06-09 Purchase |
2023-06-12 4:03 pm |
Day One Biopharmaceuticals Inc. | DAWN | AI Day1 LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
769,230 | $13 | $9,999,990 | 11,453,868 (Direct) |
View |
| 2023-06-05 Sale |
2023-06-07 4:51 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
1,229 | $16 | $19,664 | 2,234,363 (Indirect Direct) |
View |
| 2023-05-16 Sale |
2023-05-17 6:36 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
955 | $13.12 | $12,532 | 310,048 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-17 6:31 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
692 | $13.12 | $9,081 | 2,267,596 (Indirect Direct) |
View |
| 2023-05-16 Sale |
2023-05-17 6:27 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
3,104 | $13.12 | $40,732 | 1,844,760 (Indirect Direct) |
View |
| 2023-03-10 Sale |
2023-03-14 6:19 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
10,000 | $18.05 | $180,484 | 2,233,660 (Indirect Direct) |
View |
| 2023-03-07 Sale |
2023-03-08 5:50 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
12,500 | $20.01 | $250,114 | 1,737,424 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-15 Exercise |
2024-02-20 6:48 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL |
8,399 | $0 | 123,736 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-20 6:36 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY |
10,250 | $0 | 411,504 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-20 6:26 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF RESEARCH AND DEVELOPME |
8,686 | $0 | 2,359,732 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-20 6:14 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER |
19,999 | $0 | 2,018,042 (Direct) |
View |
| 2024-01-17 Option Award |
2024-01-19 5:22 pm |
N/A 2034-01-16 |
Day One Biopharmaceuticals Inc. | DAWN | Grossman William Director |
66,660 | $0 | 66,660 (Direct) |
View |
| 2024-01-17 Option Award |
2024-01-19 5:19 pm |
N/A 2034-01-16 |
Day One Biopharmaceuticals Inc. | DAWN | Dable Habib J Director |
66,660 | $0 | 66,660 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 7:29 pm |
N/A 2034-01-04 |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
268,000 | $0 | 268,000 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 7:25 pm |
N/A 2034-01-04 |
Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam General Counsel |
149,000 | $0 | 149,000 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 7:22 pm |
N/A 2034-01-04 |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Head of Research and Developme |
245,000 | $0 | 245,000 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 7:17 pm |
N/A 2034-01-04 |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
473,000 | $0 | 473,000 (Direct) |
View |
| 2023-11-15 Exercise |
2023-11-17 6:33 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
3,625 | $0 | 308,170 (Direct) |
View |
| 2023-11-15 Exercise |
2023-11-17 6:30 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam General Counsel |
13,600 | $0 | 67,978 (Direct) |
View |
| 2023-11-15 Exercise |
2023-11-17 6:26 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Head of Research and Developme |
2,624 | $0 | 2,264,990 (Direct) |
View |
| 2023-11-15 Exercise |
2023-11-17 6:20 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
8,312 | $0 | 1,838,657 (Direct) |
View |
Ownership |
2023-11-16 8:39 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam General Counsel |
0 | $0 | 472,291 (Direct) |
View |
| 2023-08-15 Exercise |
2023-08-17 7:02 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
3,625 | $0 | 309,126 (Direct) |
View |
| 2023-08-15 Exercise |
2023-08-17 6:21 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Head of Research and Developme |
2,624 | $0 | 2,265,699 (Direct) |
View |
| 2023-08-15 Exercise |
2023-08-17 6:16 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
8,312 | $0 | 1,841,764 (Direct) |
View |
| 2023-07-01 Gift |
2023-07-05 7:47 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
329,963 | $0 | 1,449,710 (Direct) |
View |
| 2023-07-01 Other |
2023-07-05 7:47 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
240,288 | $0 | 1,449,710 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-21 |
Day One Biopharmaceuticals Inc. | DAWN | Ramasastry Saira Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:44 pm |
N/A 2033-06-21 |
Day One Biopharmaceuticals Inc. | DAWN | Nicholson Garry A Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:39 pm |
N/A 2033-06-21 |
Day One Biopharmaceuticals Inc. | DAWN | Josey John A. Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:35 pm |
N/A 2033-06-21 |
Day One Biopharmaceuticals Inc. | DAWN | Holles Natalie C. Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:24 pm |
N/A 2033-06-21 |
Day One Biopharmaceuticals Inc. | DAWN | Gladstone Michael Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:19 pm |
N/A 2033-06-21 |
Day One Biopharmaceuticals Inc. | DAWN | Garland J. Scott Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:15 pm |
N/A 2033-06-21 |
Day One Biopharmaceuticals Inc. | DAWN | Becker Daniel J. Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2023-05-15 Exercise |
2023-05-17 6:36 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
3,625 | $0 | 310,048 (Direct) |
View |
| 2023-05-15 Exercise |
2023-05-17 6:31 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
2,624 | $0 | 2,267,596 (Direct) |
View |
| 2023-05-15 Exercise |
2023-05-17 6:27 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
8,312 | $0 | 1,844,760 (Direct) |
View |